http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 26 Feb 2026 19:22:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26073503.html si-local-file:///var/storage/secattach/20260226/26073503.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26073503.html Thu, 26 Feb 2026 19:22:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26073503.html si-local-file:///var/storage/secattach/20260226/26073503.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26073503.html Thu, 26 Feb 2026 19:22:00 -0500 BOLT O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Press+Releases/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html <p>REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will participate in two upcoming conferences in March:</p> <ul type="disc"><li><strong>TD Cowen 46th Annual Health Care Conference</strong><br/>Company presentation on Monday, March 2, 2026 at 9:50 a.m. EST (6:50 a.m. PST)<br/></li><li><strong>Leerink Partners Global Healthcare Conference</strong><br/>Participating in 1x1 meetings on Wednesday, March 11, 2026</li></ul> <p><strong>About Bolt Biotherapeutics, Inc.</strong><br/>The mission of Bolt Biotherapeutics is to harness the power of the immune system to improve lives and eradicate cancer. The Company is http://www.streetinsider.com/Globe+Newswire/Bolt+Biotherapeutics+to+Participate+in+Upcoming+March+Conferences/26047028.html Tue, 24 Feb 2026 08:00:00 -0500 A.20613440 A.50100012 BOLT O.00188458 O.07579093 O.49824918 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26016110.html si-local-file:///var/storage/secattach/20260217/26016110.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26016110.html Tue, 17 Feb 2026 20:11:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26016110.html si-local-file:///var/storage/secattach/20260217/26016110.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Pivotal+bioVenture+Partners+Fund+I%2C+L.P./26016110.html Tue, 17 Feb 2026 20:11:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Vivo+Panda+Fund%2C+L.P./26002525.html si-local-file:///var/storage/secattach/20260213/26002525.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Vivo+Panda+Fund%2C+L.P./26002525.html Fri, 13 Feb 2026 18:48:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Vivo+Panda+Fund%2C+L.P./26002525.html si-local-file:///var/storage/secattach/20260213/26002525.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Bolt+Biotherapeutics%2C++++++++++++++++++Filed+by%3A+Vivo+Panda+Fund%2C+L.P./26002525.html Fri, 13 Feb 2026 18:48:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Quinn+William+P./25947664.html si-local-file:///var/storage/secattach/20260204/25947664.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Quinn+William+P./25947664.html Wed, 04 Feb 2026 16:33:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Quinn+William+P./25947664.html si-local-file:///var/storage/secattach/20260204/25947664.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Quinn+William+P./25947664.html Wed, 04 Feb 2026 16:33:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Nemec+Sarah/25947646.html si-local-file:///var/storage/secattach/20260204/25947646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Nemec+Sarah/25947646.html Wed, 04 Feb 2026 16:32:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Nemec+Sarah/25947646.html si-local-file:///var/storage/secattach/20260204/25947646.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Nemec+Sarah/25947646.html Wed, 04 Feb 2026 16:32:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Yonehiro+Grant/25947653.html si-local-file:///var/storage/secattach/20260204/25947653.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Yonehiro+Grant/25947653.html Wed, 04 Feb 2026 16:32:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Yonehiro+Grant/25947653.html si-local-file:///var/storage/secattach/20260204/25947653.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Jan+28++Filed+by%3A+Yonehiro+Grant/25947653.html Wed, 04 Feb 2026 16:32:00 -0500 BOLT O.49824918 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Dec+12++Filed+by%3A+ONETTO+NICOLE/25748068.html si-local-file:///var/storage/secattach/20251216/25748068.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Bolt+Biotherapeutics%2C+++++For%3A+Dec+12++Filed+by%3A+ONETTO+NICOLE/25748068.html Tue, 16 Dec 2025 17:15:00 -0500 BOLT O.49824918